NTI drugs with moderate to high variability [Regulatives / Guidelines]

posted by arl_stat – India, 2015-12-10 07:53 (3850 d 14:05 ago) – Posting: # 15714
Views: 4,873

Hello Everyone.

Greetings!!!

The BE criteria for NTI drugs is 90-111%. It is expected to have a low variability for NTI drugs.
What is the BE criteria for known NTI drugs who possess moderate to high variability?

Thank you.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
167 visitors (0 registered, 167 guests [including 28 identified bots]).
Forum time: 22:58 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5